Literature DB >> 2496326

Regionally selective alterations in enzymatic activities and metabolic fluxes during thiamin deficiency.

G Gibson1, P Nielsen, V Mykytyn, K Carlson, J Blass.   

Abstract

To further elucidate the molecular basis of the selective damage to various brain regions by thiamin deficiency, changes in enzymatic activities were compared to carbohydrate flux through various pathways from vulnerable (mammillary bodies and inferior colliculi) and nonvulnerable (cochlear nuclei) regions after 11 or 14 days of pyrithiamin-induced thiamin deficiency. After 11 days, large decreases (-43 to -59%) in transketolase (TK) occurred in all 3 regions; 2-ketoglutarate dehydrogenase (KGDHC) declined (-45%), but only in mammillary bodies; pyruvate dehydrogenase (PDHC) was unaffected. By day 14, TK remained reduced by 58%-66%; KGDHC was now reduced in all regions (-48 to -55%); PDHC was also reduced (-32%), but only in the mammillary bodies. Thus, the enzyme changes did not parallel the pathological vulnerability of these regions to thiamin deficiency. 14CO2 production from 14C-glucose labeled in various positions was utilized to assess metabolic flux. After 14 days, CO2 production in the vulnerable regions declined severely (-46 to 70%) and approximately twice as much as those in the cochlear nucleus. Also by day 14, the ratio of enzymatic activity to metabolic flux increased as much as 56% in the vulnerable regions, but decreased 18 to 30% in the cochlear nuclei. These differences reflect a greater decrease in flux than enzyme activities in the two vulnerable regions. Thus, selective cellular responses to thiamin deficiency can be demonstrated ex vivo, and these changes can be directly related to alterations in metabolic flux. Since they cannot be related to enzymatic alterations in the three regions, factors other than decreases in the activity of these TPP-dependent enzymes must underlie selective vulnerability in this model of thiamin deficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496326     DOI: 10.1007/bf00969752

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine.

Authors:  M K Gaitonde; N A Fayein; A L Johnson
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

2.  Thiamin deficiency and the pentose phosphate cycle in rats: intracerebral mechanisms.

Authors:  D W McCandless; A D Curley; C E Cassidy
Journal:  J Nutr       Date:  1976-08       Impact factor: 4.798

Review 3.  The role of the cholinergic system in thiamin deficiency.

Authors:  G Gibson; L Barclay; J Blass
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome.

Authors:  J P Blass; G E Gibson
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

5.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

6.  Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal.

Authors:  G E Gibson; H Ksiezak-Reding; K F Sheu; V Mykytyn; J P Blass
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

7.  Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms.

Authors:  D W McCandless; S Schenker; M Cook
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

8.  Acetylcholine synthesis and CO2 production from variously labeled glucose in rat brain slices and synaptosomes.

Authors:  H J Ksiezak; G E Gibson
Journal:  J Neurochem       Date:  1981-07       Impact factor: 5.372

9.  Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency.

Authors:  A M Hakim; H M Pappius
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  Impairment of behavior and acetylcholine metabolism in thiamine deficiency.

Authors:  L L Barclay; G E Gibson; J P Blass
Journal:  J Pharmacol Exp Ther       Date:  1981-06       Impact factor: 4.030

View more
  7 in total

Review 1.  Thiamine in excitable tissues: reflections on a non-cofactor role.

Authors:  L Bettendorff
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

2.  Glucose loading precipitates acute encephalopathy in thiamin-deficient rats.

Authors:  C Zimitat; P F Nixon
Journal:  Metab Brain Dis       Date:  1999-03       Impact factor: 3.584

Review 3.  Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  P R Martin; B A McCool; C K Singleton
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

4.  Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability.

Authors:  Q Shi; S S Karuppagounder; H Xu; D Pechman; H Chen; G E Gibson
Journal:  Neurochem Int       Date:  2007-04-07       Impact factor: 3.921

Review 5.  Update on Thiamine Triphosphorylated Derivatives and Metabolizing Enzymatic Complexes.

Authors:  Lucien Bettendorff
Journal:  Biomolecules       Date:  2021-11-07

6.  Widespread episodic thiamine deficiency in Northern Hemisphere wildlife.

Authors:  Lennart Balk; Per-Åke Hägerroth; Hanna Gustavsson; Lisa Sigg; Gun Åkerman; Yolanda Ruiz Muñoz; Dale C Honeyfield; Ulla Tjärnlund; Kenneth Oliveira; Karin Ström; Stephen D McCormick; Simon Karlsson; Marika Ström; Mathijs van Manen; Anna-Lena Berg; Halldór P Halldórsson; Jennie Strömquist; Tracy K Collier; Hans Börjeson; Torsten Mörner; Tomas Hansson
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

Review 7.  The Inferior Colliculus in Alcoholism and Beyond.

Authors:  Tanuja Bordia; Natalie M Zahr
Journal:  Front Syst Neurosci       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.